SERUM CORTISOL LEVELS IN ASSESSING SEVERITY OF ACUTE STROKE – A CROSS SECTIONAL STUDY IN CHENGALPET MEDICAL COLLEGE & HOSPITAL

Main Article Content

Dr. K. Ilanchetchenni
Dr. J. Chandru
Dr. S. Senthil Kumar
Dr. G. Nishanthi

Keywords

Serum Cortisol Levels, Severity of Acute Stroke

Abstract

Background: In this study we wanted to determine whether the severity of an acute stroke could be correlated with a single measurement of blood cortisol.


Methods: After receiving approval from the institutional ethics committee and signed informed consent from the study participants, a cross-sectional study was carried out on 120 acute stroke patients who presented from Chengalpattu Government Hospital's medical wards and intensive care unit within 24 hours of the stroke beginning. All patient clinical data was concealed from the analysing laboratories. The independent sample t-test was used to calculate the parameter mean values. By using the Chi-Square test, the relationship between blood cortisol levels and stroke scores was evaluated. SPSS, a software programme used for statistical analysis, is used for all statistical analyses. It was determined that a p-value of less than 0.05 was statistically significant.


Results: 50% of the group are male and 50% are female, with an average age range of 50 to 59. The cortisol level was 637 nmol/L on average. Acute ischemic stroke affected 98 out of the 120 patients, while acute hemorrhagic stroke affected 22. The average time was 9.5 hours, and the average SSS score was 20.85. The SSS and serum cortisol correlation coefficient was -0.984, showing a significant link. High serum cortisol levels were associated with lower SSS scores, and the p-value was < 0.001, indicating statistical significance.


Conclusion: Elevations in blood cortisol levels are associated with acute stroke severity. One potential indicator of the severity of a stroke is serum cortisol.

Abstract 296 | pdf Downloads 197

References

1. Raj T. Adrenal cortex. Guyton & Hall textbook of medical physiology. Raj T, Kurpad A, Vaz M, Hall J, eds Amsterdam, Netherlands: Elsevier 2013:590-604.
2. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985;229(4720):1397-400.
3. Samuels MA. The brain-heart connection. Circulation 2007;116(1):77-84.
4. Handaayani IA, Hamdan M, Sugianto P, Sani AF, Ardhi MS, Rahardjo JEW. The impact of high cortisol level in increasing incidence of infection cases among acute stroke patients. J Comput Theor Nanosci 2020,17(7):3079-84.
5. Zi WJ, Shuai J. Cortisol as a prognostic marker of short-term outcome in Chinese patients with acute ischemic stroke. PLoS One 2013;8:e72758.
6. Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 2011;269(4):420-32.
7. Anne M, Juha K, Timo M, Mikko T, Olli V, Kyosti S, et al. Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality. Curr Neurovasc Res 2007;4(3):170-5.
8. Marklund N, Peltonen M, Nilsson TK, Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 2004;256(1):15-21.
9. Brown ES, J Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004;55(5):538-45.
10. Feibel JH, Hardy PM, Campbell GC, Goldstein MN, Joynt RJ. Prognostic value of the stress response following stroke. JAMA 1977;238(13):1374-6.
11. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985;229(4720):1397-400.
12. Agarwal A, Iqbaal H. Serum-cortisol levels in severity of stroke. International Journal of Medical and Biomedical Studies 2020;4(2):202-5.
13. Christensen H, Boysen G, Johannesen HH. Serum-cortisol reflects severity and mortality in acute stroke. Journal of the Neurological Sciences 2004;217(2):175-80.
14. Zierath D, Tanzi P, Cain K, Shibata D, Becker K. Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke. Stroke 2011;42(12):3415-20.
15. Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 2011;269(4):420-32.
16. Iranmanesh F, Sedighi B, Ziaadini B. Prognostic value of cortisol in patients with acute ischemic stroke .Zahedan J Res Med Sci 2017;19:e6187.
17. Theodoropoulou A, Metallinos IC, Elloul J, Taleli P, Lekka N, Vagenakis AG, et al. Prolactin, cortisol secretion and thyroid function in patients with stroke of mild severity. Horm Metab Res 2006,38(9):587-91.
18. Fassbender K, Schmidt R, Mössner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 1994;25(6):1105-8.
19. Marklund N, Peltonen M, Nilsson TK, Olsson T. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 2004;256(1):15-21.
20. DeGraba TJ, Hallenbech JM, Petigrew KD, Dutka AJ, Kelly BJ. Progression in acute stroke. Stroke 1999;30(6):1208-12.
21. Neidert S, Katan M, Schuetz P, Fluri F, Ernst A, Bingisser R, et al. Anterior pituitary axis hormones and outcome in acute ischaemic stroke. J Intern Med 2011;269(4):420-32.
22. Christensen H, Boysen G, Johannesen HH. Serum-cortisol reflects severity and mortality in acute stroke. J Neurol Sci 2004;217(2):175-80.
23. Zierath D, Tanzi P, Cain K, Shibata D, Becker K. Plasma alpha-melanocyte stimulating hormone predicts outcome in ischemic stroke. Stroke 2011;42(12):3415-20.
24. Davalos A, Ricart W, Gonzalez-Huix F, Soler S, Marrugat J, Molins A, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996;27(6):1028-32.